Independent Living — Therapeutic Relaxation, Health and Quality of Life
Citation(s)
ActiGraph, L (2018). ActiGraph wGT3X-BT. Retrieved April 10, 2018, from https://www.actigraphcorp.com/actigraph-wgt3x-bt/
Askevold F Measuring body image. Preliminary report on a new method. Psychother Psychosom. 1975;26(2):71-7.
Avalos L, Tylka TL, Wood-Barcalow N The Body Appreciation Scale: development and psychometric evaluation. Body Image. 2005 Sep;2(3):285-97. Epub 2005 Aug 26.
Bair MJ, Wu J, Damush TM, Sutherland JM, Kroenke K Association of depression and anxiety alone and in combination with chronic musculoskeletal pain in primary care patients. Psychosom Med. 2008 Oct;70(8):890-7. doi: 10.1097/PSY.0b013e318185c510. Epub 2008 Sep 16.
Baldaia, A (2013). A atratividade física e o seu contributo para o envelhecimento bem-sucedido. Actas de Gerontologia, 1(1), 1-8.
Cunha, L , & Mayrink, W. (2011). Influência da dor crônica na qualidade de vida em idosos. Revista Da Dor, 12(2), 120-124
Ferreira PL [Development of the Portuguese version of MOS SF-36. Part II --Validation tests]. Acta Med Port. 2000 May-Jun;13(3):119-27. Portuguese.
Ferreira-Valente, M A., Pais-Ribeiro, J. L., & Jensen, M. P. (2012). Further Validation of a Portuguese Version of the Brief Pain Inventory Interference Scale. Clínica Y Salud, 23(1), 89-96. http://doi.org/10.5093/cl2012a6
Machorrinho, J , Veiga, G., & Marmeleira, J. (2017). Propriedades psicométricas da versão portuguesa do Multidimentional Assessment of Interoceptive Awareness (MAIA). Universidade de Évora.
Morais A, Santos S, Lebre P Psychomotor, functional, and cognitive profiles in older people with and without dementia: What connections? Dementia (London). 2017 Jan 1:1471301217719624. doi: 10.1177/1471301217719624. [Epub ahead of print]
Morais, A , Santos, S., & Lebre, P. (2016). Psychometric Properties of the Portuguese Version of the Éxamen Geronto-Psychomoteur (P- EGP). Educational Gerontology. http://doi.org/10.1080/03601277.2016.1165068
Neves, C F., Price, C. J., & Carvalheira, A. (2017). The psychometric properties of the Scale of Body Connection (SBC) in a Portuguese sample. Psychology, Community & Health, 6(1), 158-169. http://doi.org/10.5964/pch.v6i1.223
Orsal O, Alparslan GB, Ozkaraman A, Sönmez N The effect of relaxation exercises on quality of sleep among the elderly: holistic nursing practice review copy. Holist Nurs Pract. 2014 Jul-Aug;28(4):265-74. doi: 10.1097/HNP.0000000000000032.
Rubenstein LZ Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing. 2006 Sep;35 Suppl 2:ii37-ii41. Review.
Tel, H (2013). Sleep quality and quality of life among the elderly people. Neurology Psychiatry and Brain Research, 19(1), 48-52. http://doi.org/10.1016/j.npbr.2012.10.002
Viana, M F., Almeida, P. L. de, & Santos, R. C. (2001). Adaptação portuguesa da versão reduzida do Perfil de Estados de Humor - POMS. Análise Psicológica, 1(19), 77-92. Retrieved from http://publicacoes.ispa.pt/index.php/ap/article/view/345
World Health Organization (2017). Mental health of older adults. Retrieved from http://www.who.int/mediacentre/factsheets/fs381/en/
Effects of Two Therapeutic Relaxation Programs on Health and Quality of Life Indicators of Elderly People Living in the Community
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
